Chronic captopril administration decreases vasodilator responses in skeletal muscle arterioles

American Journal of Hypertension

Volumn 12, Issue 7, 1999, Pages 705-715

  Frisbee, Jefferson C ^a   Weber, David S ^a   Lombard, Julian H ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Angiotensin converting enzyme inhibition; Remodeling; Vascular reactivity

Indexed keywords

ACETYLCHOLINE; ADENOSINE; CALCIUM; CAPTOPRIL; CHOLERA TOXIN; DIPEPTIDYL CARBOXYPEPTIDASE; FORSKOLIN; ILOPROST; NITROPRUSSIDE SODIUM; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY DIAMETER; ARTERY DILATATION; ARTERY WALL; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; CREMASTER MUSCLE; ENZYME INHIBITION; MICROCIRCULATION; MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; RAT; TOPICAL DRUG ADMINISTRATION;

ACETYLCHOLINE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ARTERIOLES; BLOOD PRESSURE; CAPTOPRIL; CHOLERA TOXIN; DRUG ADMINISTRATION ROUTES; FOLLOW-UP STUDIES; FORSKOLIN; ILOPROST; MUSCLE, SKELETAL; NITROPRUSSIDE; RATS; RATS, SPRAGUE-DAWLEY; VASODILATION; VASODILATOR AGENTS; VIDEO RECORDING;

EID: 0033066334     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(99)00043-6     Document Type: Article

References (21)

1. Weber D.S., Greene A.S., Lombard J.H. Effect of short term and chronic high salt diet on vasodilator responses of skeletal muscle resistance arteries (abst). FASEB J. 1997;A43.
2. 2 and vasodilators during hypertension and elevated salt intake. Am J Physiol. 273:1997;H869-H877.
3. 2 and prostacyclin via suppression of angiotensin II (abst). Microcirculation 1997;4:159.
4. Frisbee J.C., Lombard J.H. Chronic elevations in salt intake and reduced renal mass hypertension compromise mechanisms of arteriolar dilation. Microvasc Res. 56:1998;218-227.
5. Hernandez I., Cowley A.W. Jr, Lombard J.H., Greene A.S. Salt intake and angiotensin II alter microvessel density in the cremaster muscle of normal rats. Am J Physiol. 263:1992;H664-H667.
6. Wang D.H., Prewitt R.L. Captopril reduced aortic and microvascular growth in hypertensive and normotensive rats. Hypertension. 15:1990;68-77.
7. Wang D.H., Prewitt R.L. Longitudinal effect of captopril on aortic and arteriolar development in normotensive rats. Am J Physiol. 260:1991;H1959-H1965.
8. Scheidegger K.J., Wood J.M., van Essen H., Struijker-Boudier H.A. Effects of prolonged blockade of the renin-angiotensin system on striated muscle microcirculation of spontaneously hypertensive rats. J Pharm Exp Ther. 278:1996;1276-1281.
9. Lombard JH, Hinojosa-Laborde C, Cowley AW Jr. Hemodynamics and microcirculatory alterations in reduced renal mass hypertension. Hypertension 1989;13:128-138.
10. Zusman R.M. Effects of converting-enzyme inhibitors on the renin-angiotensin-aldosterone, bradykinin, and arachidonic acid-prostaglandin systems correlation of chemical structure and biological activity . Am J Kid Dis. 10:1987;13-23.
11. Berk B.C., Vekshtein V., Gordon H.M., Tsuda T. Angiotensin-II stimulated protein synthesis in cultured vascular smooth muscle cells. Hypertension. 13:1989;305-314.
12. Gersterfer A.A.T., Peach M.J., Owens G.K. Angiotensin II induces hypertrophy, not hyperplasia of cultured rat aortic smooth muscle cells. Circ Res. 62:1998;749-756.
13. Hansen-Smith F.M., Morris L.W., Greene A.S., Lombard J.H. Rapid microvessel rarefaction with elevated salt intake and reduced renal mass hypertension in rats. Circ Res. 79:1996;324-330.
14. Rieder M.J., Roman R.J., Greene A.S. Reversal of microvascular rarefaction and reduced renal mass hypertension. Hypertension. 30:1997;120-127.
15. Brooks V.L. Interactions between angiotensin II and the sympathetic nervous system in the long term control of arterial pressure. Clin Exp Pharmacol Physiol. 24:1997;83-90.
16. Atkinson A.B., Morton J.J., Brown J.J., et al. Captopril in clinical hypertension. Changes in components of renin-angiotensin system and in body composition in relation to fall in blood pressure with a note on measurement of angiotensin II during converting enzyme inhibition. Br Heart J. 44:1980;290-296.
17. Luscher A.T.F. Angiotensin, ACE-inhibitors and endothelial control of vasomotor tone. Basic Res Cardiol. 88:(suppl 1):1993;15-24.
18. Mombouli J.V. ACE inhibition, endothelial function and coronary artery lesions. Role of kinins and nitric oxide. Drugs. 54:(suppl 5):1997;12-22.
19. Ruschitzka F.T., Noll G., Luscher T.F. Combination of ACE inhibitors and calcium antagonists a logical approach . J Cardiovasc Pharmacol. 31:(suppl 2):1998;S5-S16.
20. Campbell D.J. Angiotensin converting enzyme (ACE) inhibitors and kinin metabolism evidence that ACE inhibitors may inhibit a kininase other than ACE . Clin Exp Pharmacol Physiol. 22:1995;903-911.
21. Frisbee JC, Lombard JH: Altered microvessel reactivity in hypertensive and normotensive rats during changes in dietary salt intake (abst). FASEB J 1998;12:A13.